Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 1.86B P/E - EPS this Y 39.90% Ern Qtrly Grth -
Income -323.99M Forward P/E -16.61 EPS next Y 53.90% 50D Avg Chg -17.00%
Sales 234.04M PEG -0.14 EPS past 5Y - 200D Avg Chg -21.00%
Dividend N/A Price/Book N/A EPS next 5Y 11.60% 52W High Chg -42.00%
Recommedations 2.10 Quick Ratio 3.16 Shares Outstanding 104.22M 52W Low Chg 34.00%
Insider Own 8.47% ROA -26.02% Shares Float 70.71M Beta 1.09
Inst Own 89.23% ROE - Shares Shorted/Prior 11.63M/10.87M Price 22.09
Gross Margin 34.98% Profit Margin -138.43% Avg. Volume 1,336,822 Target Price 14.91
Oper. Margin -73.19% Earnings Date May 6 Volume 1,018,168 Change -4.12%
About Revance Therapeutics, Inc.

Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DAXXIFY (DaxibotulinumtoxinA-lanm) for injection for the treatment of glabellar lines and cervical dystonia; has completed phase II clinical trials to treat upper facial lines, moderate or severe dynamic forehead lines, and moderate or severe lateral canthal lines; and has completed Phase II clinical trials for the treatment of adult upper limb spasticity and plantar fasciitis. It is also developing OnabotulinumtoxinA, a biosimilar to BOTOX that is in preclinical stage. The company also offers Resilient Hyaluronic Acid (RHA) dermal filler for the correction of moderate to severe dynamic facial wrinkles; and RHA Redensity, a dermal filler for the treatment of moderate to severe dynamic perioral rhytids. It has a collaboration and license agreement with Viatris Inc. to develop, manufacture, and commercialize onabotulinumtoxinA. The company was formerly known as Essentia Biosystems, Inc. and changed its name to Revance Therapeutics, Inc. in April 2005. Revance Therapeutics, Inc. was incorporated in 1999 and is headquartered in Nashville, Tennessee.

Revance Therapeutics, Inc. News
04/12/24 Revance to Present New DAXXIFY® Data at the American Academy of Neurology 2024 Annual Meeting
04/12/24 Revance Therapeutics, Inc. (NASDAQ:RVNC) is favoured by institutional owners who hold 63% of the company
03/27/24 Revance Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03/04/24 Revance Announces Pricing of $100.0 Million Public Offering of Common Stock
03/04/24 Revance Announces Proposed Public Offering of Common Stock
08:23 AM Revance Therapeutics, Inc. (NASDAQ:RVNC) Q4 2023 Earnings Call Transcript
07:45 AM US$16.33: That's What Analysts Think Revance Therapeutics, Inc. (NASDAQ:RVNC) Is Worth After Its Latest Results
03/01/24 Revance Therapeutics Full Year 2023 Earnings: Beats Expectations
02/29/24 Q4 2023 Revance Therapeutics Inc Earnings Call
02/28/24 Revance Therapeutics Inc (RVNC) Reports Strong Revenue Growth in Q4 and Full Year 2023
02/28/24 Revance Reports Fourth Quarter and Full Year 2023 Financial Results, Provides Corporate Update
02/21/24 Revance to Release Fourth Quarter and Full Year 2023 Financial Results on Wednesday February 28, 2024
02/21/24 Revance to Participate in Upcoming Investor Conferences
02/20/24 Halozyme Therapeutics (HALO) Q4 Earnings Match Estimates
08:00 AM Revance Receives Permanent J-Code for DAXXIFY® and Announces Publication of DAXXIFY Pivotal Study (ASPEN-1) Results in Neurology®
02/01/24 Revance to Participate in the Guggenheim 6th Annual Biotechnology Conference
01/30/24 Shareholders in Revance Therapeutics (NASDAQ:RVNC) are in the red if they invested a year ago
01/08/24 Revance Provides Corporate Update, Preliminary Fourth Quarter and Full Year 2023 Financial Results, and Financial Outlook
11/10/23 Analysts Just Slashed Their Revance Therapeutics, Inc. (NASDAQ:RVNC) EPS Numbers
11/09/23 Revance Therapeutics, Inc. (NASDAQ:RVNC) Q3 2023 Earnings Call Transcript
RVNC Chatroom

User Image making_money81 Posted - 13 hours ago

$RVNC run!!

User Image Stock1701 Posted - 16 hours ago

$RVNC Added another 1k shares to average down.

User Image making_money81 Posted - 04/30/24

$RVNC annual shareholder meeting tomorrow morning. Hopefully they give us some good news.

User Image Stone52 Posted - 04/29/24

$RVNC up on volume

User Image making_money81 Posted - 04/29/24

$RVNC well, let’s hope the bottom is in. Nice to see a couple Green Days in a row.

User Image Stock1701 Posted - 04/29/24

$RVNC Finally running!!

User Image thevoiceofl Posted - 04/29/24

$RVNC A lot of volume this morning, including 5/17 calls... 👀

User Image wowster Posted - 04/27/24

$RVNC word is getting out there - https://www.instagram.com/reel/C6PLozoSc2h/?igsh=cHpqMWFzbzZheG5t

User Image Stone52 Posted - 04/26/24

$RVNC correction - I listened to a replay of ABBV conf call. They said we maintain a, despite a new competitor, strong market share. It was said quickly - and I had picked up “new competitor strong”

User Image Stone52 Posted - 04/26/24

$RVNC mentioned as “strong competitor” on $ABBV conference call when discussing aesthetics

User Image IFeelLucky812 Posted - 04/26/24

$RVNC Daxi sales are improving from the poor launch, product wasn’t priced right, it’s been fixed and seeing more volume. Will start gaining some traction on the medical side as well. Next step is international. Things should be on the up.

User Image TheMAGATrader Posted - 04/25/24

$RVNC I think I deserve an apology from many on here for being the only one on the money. Don't worry, I'm sure this trash company will "go to the moon." 🫡🤣

User Image Stock1701 Posted - 04/25/24

$RVNC Not falling for their games. I will keep adding to lower my average as long as revenues keeps growing .

User Image St0ckt0k101 Posted - 04/25/24

$RVNC bottomless PIT HERE! 😳💀📉💯

User Image michael23 Posted - 04/25/24

$RVNC Stock Price 52 week high 37.98 the low 3.23.Nevervthought be here maybe 8 to 10

User Image Stone52 Posted - 04/25/24

$RVNC if we can double the volume here and go positive - it could be a short-term bottom. If they had a lousy quarter, then we start the descent all over again.

User Image Riverrat20 Posted - 04/25/24

$RVNC I think I see where this is headed 🙄

User Image divesdeeper Posted - 04/25/24

$RVNC this is near term bankruptcy price action. Has management issued a going concern?

User Image loki_doki Posted - 04/25/24

$RVNC headed for 2s eom

User Image ajwolf Posted - 04/25/24

$RVNC just watching this thing swirl around the toilet bowl going down... down... down...

User Image making_money81 Posted - 04/25/24

$RVNC will be interesting to see where this bottoms… I have a feeling $3s is not the bottom, unfortunately

User Image Stock1701 Posted - 04/25/24

$RVNC Got another 500 shares. This one is becoming one of my biggest bags. Bottom can’t be far away. Raise and CEO all bought in at above 6.

User Image Stone52 Posted - 04/25/24

$RVNC sold all of my married puts over the last few days. I’m hoping we’re nearing the end of this slaughter

User Image Stock1701 Posted - 04/25/24

$RVNC Interesting price action for a company who’s revenue keeps growing. Might have to add some more today.

User Image IFeelLucky812 Posted - 04/25/24

$RVNC I should be able to get some insight on Daxi progress today, I’ll report back if I do. Can’t believe this thing is still in free fall. I’m waiting for a clear bottom to double up.

User Image majormalfunction Posted - 04/24/24

$RVNC hopefully , they’ll get international dax going and then get some better financials to help stock grow again .

User Image loki_doki Posted - 04/24/24

$RVNC there's no bottom

User Image wowster Posted - 04/24/24

$RVNC still am amazed at how fast the destruction of this company - Foley needs to go

User Image wowster Posted - 04/24/24

$RVNC where is the bottom?

User Image ajwolf Posted - 04/24/24

$RVNC anyone know if voting has ended and the results. I hope it is a wake up call to this god awful management.

Analyst Ratings
Goldman Sachs Neutral Mar 1, 24
HC Wainwright & Co. Buy Feb 29, 24
Piper Sandler Overweight Feb 29, 24
Needham Buy Feb 29, 24
HC Wainwright & Co. Buy Feb 23, 24
Barclays Overweight Jan 29, 24
Mizuho Neutral Jan 29, 24
Needham Buy Jan 9, 24
Goldman Sachs Neutral Jan 9, 24
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Moxie Dwight SVP, GC & Secretary SVP, GC & Secretary Sep 05 Sell 17.44 34,853 607,836 44,066 09/07/23
Foley Mark J CEO CEO Aug 03 Sell 22.5713 26,279 593,151 840,375 08/04/23
Schilke Tobin CFO CFO Jun 30 Sell 25.04 1,701 42,593 79,896 07/05/23
Foley Mark J CEO CEO Jun 30 Sell 24.94 26,279 655,398 866,654 07/05/23
Sjuts Dustin S President President Jun 09 Sell 30.8192 5,000 154,096 147,347 06/13/23
Foley Mark J CEO CEO Jun 09 Sell 30.7212 31,279 960,928 891,933 06/13/23
Moxie Dwight SVP, GC & Secretary SVP, GC & Secretary Feb 02 Sell 34.55 21,401 739,405 69,165 05/16/23
Schilke Tobin CFO CFO Feb 02 Sell 34.55 21,401 739,405 84,029 05/16/23
Foley Mark J CEO CEO Feb 02 Sell 34.55 70,447 2,433,944 923,212 05/16/23
Sjuts Dustin S President President Feb 02 Sell 34.55 21,015 726,068 152,347 05/16/23
Moxie Dwight SVP, GC & Secretary SVP, GC & Secretary Sep 22 Sell 31.59 18,496 584,289 55,547 03/09/23
Schilke Tobin CFO CFO Sep 22 Sell 31.59 18,517 584,952 73,222 03/09/23
Sjuts Dustin S President President Sep 22 Sell 31.59 21,508 679,438 123,934 03/09/23
Foley Mark J CEO CEO Sep 22 Sell 31.59 70,390 2,223,620 823,351 03/09/23
Schilke Tobin CFO CFO Mar 01 Sell 33.50 3,201 107,234 49,390 03/02/23
Schilke Tobin CFO CFO Jan 31 Sell 34.60 3,201 110,755 54,676 02/02/23
Schilke Tobin CFO CFO Jan 20 Sell 31 1,000 31,000 57,877 01/23/23
Schilke Tobin CFO CFO Jan 09 Sell 27.67 3,701 102,407 58,877 01/10/23